Cargando…
Digital health technologies and Alzheimer’s disease clinical trials: might decentralized clinical trials increase participation by people with cognitive impairment?
BACKGROUND: Therapeutic trials in Alzheimer’s disease (AD) face many obstacles—particularly with regard to screening and recruitment. DISCUSSION: Decentralized clinical trials (DCTs) are being developed in other diseases and appear to be of value for overcoming these difficulties. The use of remote...
Autores principales: | Leroy, Victoire, Gana, Wassim, Aïdoud, Amal, N’kodo, Jacques-Alexis, Balageas, Anna-Chloé, Blanc, Pascal, Bomia, Dominique, Debacq, Camille, Fougère, Bertrand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133908/ https://www.ncbi.nlm.nih.gov/pubmed/37106429 http://dx.doi.org/10.1186/s13195-023-01227-4 |
Ejemplares similares
-
High Prevalence of Geriatric Conditions Among Older Adults With Cardiovascular Disease
por: Aïdoud, Amal, et al.
Publicado: (2023) -
Analysis of the Impact of Selected Vitamins Deficiencies on the Risk of Disability in Older People
por: Gana, Wassim, et al.
Publicado: (2021) -
Neuroinflammation: A Possible Link Between Chronic Vascular Disorders and Neurodegenerative Diseases
por: Moyse, Emmanuel, et al.
Publicado: (2022) -
Redundant trials can be prevented, if the EU clinical trial regulation is applied duly
por: Kim, Daria, et al.
Publicado: (2020) -
Applying implementation frameworks to the clinical trial context
por: Stensland, Kristian D., et al.
Publicado: (2022)